Celularity (CELUW) Capital Expenditures (2020 - 2024)
Celularity (CELUW) reported Capital Expenditures of $91000.0 for Q4 2024, down 69.26% year-over-year from $296000.0 in Q1 2024, and up 54.24% quarter-over-quarter from $59000.0 in Q2 2024.
Celularity (CELUW) Capital Expenditures (2020 - 2024) Analysis & Trends
Celularity (CELUW) has 5 years of Capital Expenditures data on file, last reported at $91000.0 in Q4 2024.
- Capital Expenditures for Q4 2024 came in at $91000.0, down 69.26% year-over-year; the trailing twelve-month figure through Dec 2024 was $161000.0 (down 84.64% YoY), and the FY2024 annual result was $161000.0, down 84.64% from the prior year.
- Capital Expenditures grew to $91000.0 in Q4 2024 per CELUW's latest filing, from $59000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $22.7 million in Q4 2020 and troughed at -$3.8 million in Q4 2022.
- A 5-year average of $1.9 million and a median of $291500.0 in 2021 frame the typical range for Capital Expenditures.
- On a YoY basis, Capital Expenditures climbed as much as 253.66% in 2022 and fell as far as 182.01% in 2022.
- A 5-year view of Capital Expenditures shows it stood at $22.7 million in 2020, then plunged by 79.71% to $4.6 million in 2021, then tumbled by 182.01% to -$3.8 million in 2022, then soared by 107.84% to $296000.0 in 2023, then plunged by 69.26% to $91000.0 in 2024.
- Business Quant data shows CELUW's Capital Expenditures at $91000.0 in Q4 2024, $59000.0 in Q2 2024, and $11000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Celularity | - | - | -3.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 91,000.00 |
| Dec 31, 2024 | 91,000.00 |
| Jun 30, 2024 | 59,000.00 |
| Jun 30, 2024 | 59,000.00 |
| Mar 31, 2024 | 11,000.00 |
| Mar 31, 2024 | 11,000.00 |
| Dec 31, 2023 | 296,000.00 |
| Dec 31, 2023 | 296,000.00 |
| Sep 30, 2023 | 512,000.00 |
| Sep 30, 2023 | 512,000.00 |
| Jun 30, 2023 | 31,000.00 |
| Jun 30, 2023 | 31,000.00 |
| Mar 31, 2023 | 209,000.00 |
| Mar 31, 2023 | 209,000.00 |
| Dec 31, 2022 | -3.77 Mn |
| Dec 31, 2022 | -3.77 Mn |
| Sep 30, 2022 | 1.56 Mn |
| Sep 30, 2022 | 1.56 Mn |
| Jun 30, 2022 | 1.88 Mn |
| Jun 30, 2022 | 1.88 Mn |